Search Results 301-310 of 23994 for prostate cancer
Darolutamide is used to treat patients with non-metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical ...
The purpose of this study is to compare overall survival in newly diagnosed metastatic prostate cancer patients randomly assigned to androgen deprivation ...
It helps treat prostate cancer by lowering the amount of testosterone hormone in the blood. In some patients, testosterone will cause prostate cancer to grow ...
99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates a histopathologic ...
The objective of this study is to compare perioperative and oncologic outcomes of patients undergoing open and robotic prostatectomy for prostate cancer.
Prostate cancer diagnostics and risk stratification; Trans-perineal prostate biopsy including targeted biopsy; Prostate imaging (MRI, Ultrasound); Focal ...
Mayo Clinic researchers are using genetic sequencing to improve treatments for men with advanced prostate cancer. They're attempting to understand how tumors ...
... (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Innovative ...
Prostate cancer screening · Testosterone therapy: Potential benefits and risks as you age · Vaccines for adults · Related resources at Mayo Clinic. Mayo Clinic ...
... (cancer that has already spread) castration-resistant prostate cancer (prostate cancer that cannot be treated by surgery or medicines that lower testosterone).
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.